Organogenesis Holdings, Inc. (ORGO)
3.74
-0.02
(-0.53%)
USD |
NASDAQ |
Feb 12, 16:00
3.79
+0.05
(+1.34%)
After-Hours: 20:00
Organogenesis Holdings Cash from Investing (Quarterly) : -2.235M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Integra LifeSciences Holdings Corp. | -15.59M |
| Celularity, Inc. | 0.00 |
| ACADIA Pharmaceuticals, Inc. | -79.35M |
| Alnylam Pharmaceuticals, Inc. | 501.11M |
| Savara, Inc. | 21.47M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 3.079M |
| Cash from Financing (Quarterly) | -10.21M |
| Free Cash Flow | -51.65M |
| Free Cash Flow Per Share (Quarterly) | 0.0065 |
| Free Cash Flow to Equity (Quarterly) | 0.85M |
| Free Cash Flow to Firm (Quarterly) | 0.844M |
| Free Cash Flow Yield | -10.70% |